Defense attorneys for Luigi Mangione have been in discussions with federal prosecutors about a possible plea deal, CBS News reported on June 26 — days before his New York state murder trial is scheduled to begin on September 8.

Mangione, 26, of Towson, Maryland, was arrested on December 9, 2024, in Altoona, Pennsylvania, five days after Brian Thompson, CEO of UnitedHealthcare, was shot and killed outside a Midtown Manhattan hotel. He was found in possession of a firearm, ammunition, fake identification, cash, and a handwritten manifesto. He has pleaded not guilty in New York state court to murder, weapons, and forgery charges brought by Manhattan District Attorney Alvin Bragg, and separately faces federal charges — filed by the Southern District of New York — including stalking, murder, and use of a silencer in a crime of violence, per the Justice Department.

The plea discussions add a new variable to a case that has already shed complexity at several turns. In September 2025, a New York judge dismissed terrorism charges that state prosecutors had appended to the indictment, narrowing the state case to second-degree murder and related counts. Now, with AP News reporting that the defense intends to assert a psychiatric defense at trial, the legal terrain heading into September is shifting on multiple fronts simultaneously.

The Parallel Track: Federal and State Jeopardy

Mangione's exposure is bifurcated. The state case, prosecuted by the Manhattan DA's office, carries the second-degree murder charge and will go before a jury if no deal is struck. The federal case, lodged in the SDNY, includes charges under statutes that could carry the death penalty — a sentencing option unavailable under New York state law, which abolished capital punishment in 2004. That asymmetry gives federal prosecutors structural leverage in any plea negotiation, and it gives Mangione's defense team an acute incentive to resolve at least one track before the other reaches verdict.

The reported plea discussions involve the federal case. Whether any agreement would affect the state prosecution — which Bragg's office controls independently — is not established by available reporting.

The Psychiatric Defense

A notice of intent to assert a psychiatric defense is a procedurally significant step in New York, triggering mandatory reciprocal discovery: the defense must submit its experts to prosecution examination, and the prosecution may retain its own. The strategic calculus is familiar. A psychiatric defense does not require a finding of legal insanity — the full affirmative defense under New York Penal Law § 40.15, which demands that the defendant lacked the capacity to understand the nature of the act or that it was wrong. It can also be deployed more narrowly, to negate specific intent and support a charge reduction from second-degree murder to a lesser offense.

Given that Mangione was found with a written manifesto expressing grievances against the health insurance industry, the prosecution will almost certainly argue premeditation and deliberate purpose. The defense's path through a psychiatric argument is narrow but not implausible: the question of whether Mangione's apparent ideological fixation constitutes a cognizable mental disease or defect — rather than simply a motive — will likely be the core battleground for competing experts.

What the Evidence Record Looks Like

Pre-trial litigation has already touched the physical evidence. A May 2026 court ruling addressed the admissibility of backpack evidence recovered at arrest — an indication that suppression motions have been litigated and, at least in part, resolved. The manifesto, the weapons, and the fake IDs are all expected to be central prosecution exhibits. Surveillance footage from the hotel vicinity has been widely reported as part of the investigative record, though its trial admissibility has not been publicly adjudicated.

The terrorism charge dismissal last September removed what would have been the prosecution's most aggravating count, but it did not substantially alter the core factual theory of the case: that Mangione stalked and killed Thompson in a targeted act.

The September 8 trial date is current as of Reuters' May 2026 reporting. Whether plea talks produce an agreement before that date — or collapse and push the case to a jury — will determine whether this becomes one of the most closely watched criminal trials of 2026.